- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2005
- Public Summary Document (PSD) November 2005 PBAC Meeting - PDF
Efalizumab – November 2005
Efalizumab, injection set containing 4 vials powder for injection 125 mg and 4 pre-filled syringes solvent 1.3 mL, Raptiva®, November 2005
Last updated
27 February 2006